| Investigator |
Title |
Sponsor |
ID |
Dates |
Amount |
| Jacob Bleesing, MD-PHD |
Bleesing Primary Immune Deficiency Treatment Consortium |
The Univ of California, San Francisco (National Institutes of Health (NIH)) |
8404sc |
9/1/2018 - 8/31/2019 |
$24,200 |
| Christopher E Dandoy, MD |
Automated Activities of Daily Living (ADL) Adherence System to Reduce Complications after Intensive Cancer Therapy in Pediatrics |
National Institutes of Health (NIH) |
R21CA223503 |
2/1/2019 - 1/31/2020 |
$167,725 |
| Stella M Davies, MD |
Childhood Cancer Survivor Study |
St Jude's Children's Hospital (National Institutes of Health (NIH)) |
111287240-7798423 |
12/1/2018 - 11/30/2019 |
$218,151 |
| Stella M Davies, MD |
Vitamin A to Improve Gut Permeability and Reduce Infection and GVHD in Children Receiving Stem Cell Transplant |
Gateway for Cancer Research |
G17300 |
7/1/2018 - 6/30/2019 |
$119,979 |
| Arun Gurunathan, MD |
Understanding and Stopping MBLN1 |
Cancer Free Kids |
cfk |
7/1/2018 - 6/30/2020 |
$50,000 |
| Sonata Jodele, MD |
Thrombotic microangiopathy associated MODS after stem cell transplantation |
National Institutes of Health (NIH) |
R01HD093773 |
3/1/2019 - 8/31/2019 |
$635,506 |
| Michael B Jordan, MD |
Consortium for clinical and translational research in LCH |
St Jude's Children's Hospital (St. Baldrick's Foundation) |
318937 |
7/1/2018 - 6/30/2019 |
$11,720 |
| Rebecca A Marsh, MD |
Resources to Assist Investigations in Primary Immunodeficiency Diseases |
Immune Deficiency Foundation (National Institutes of Health (NIH)) |
Marsh, Rebecaa, USID |
4/1/2019 - 3/31/2020 |
$38,135 |
| Parinda Mehta, MD |
Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients with Fanconi Anemia |
Gateway for Cancer Research |
G18500 |
10/1/2018 - 9/30/2019 |
$266,666 |
| Current Year Direct |
$1,532,082 |
